Insider Selling: Trupanion (NASDAQ:TRUP) CRO Sells $219,344.80 in Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) CRO Emily Dreyer sold 7,792 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total transaction of $219,344.80. Following the completion of the transaction, the executive owned 35,627 shares in the company, valued at $1,002,900.05. This trade represents a 17.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Trupanion Stock Performance

TRUP opened at $27.44 on Monday. The company’s 50 day moving average is $31.95 and its 200 day moving average is $37.79. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.19 billion, a price-to-earnings ratio of 60.98 and a beta of 1.62. Trupanion, Inc. has a 12-month low of $25.24 and a 12-month high of $57.88.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The business had revenue of $376.85 million for the quarter, compared to analysts’ expectations of $375.89 million. During the same period in the prior year, the company posted $0.04 earnings per share. The firm’s quarterly revenue was up 11.7% on a year-over-year basis. On average, equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Wall Street Zen lowered Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Weiss Ratings cut Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday. Piper Sandler decreased their price objective on Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Finally, Stifel Nicolaus decreased their price objective on Trupanion from $38.00 to $35.00 and set a “hold” rating on the stock in a research note on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $45.50.

Read Our Latest Research Report on TRUP

Institutional Trading of Trupanion

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Millennium Management LLC raised its position in shares of Trupanion by 185.8% during the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after purchasing an additional 402,421 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Trupanion by 116.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock worth $17,826,000 after buying an additional 256,559 shares during the period. Two Sigma Investments LP boosted its holdings in Trupanion by 3,201.0% in the 3rd quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock worth $9,713,000 after buying an additional 217,634 shares during the period. Polar Capital Holdings Plc increased its stake in Trupanion by 13.5% in the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after buying an additional 175,000 shares in the last quarter. Finally, Marshall Wace LLP increased its stake in Trupanion by 15.5% in the 3rd quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock worth $52,462,000 after buying an additional 163,101 shares in the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Read More

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.